Brief: Kancera: Intention To Change Company Name To Novakand Pharma
March 7 (Reuters) - Kancera AB KANC.ST: KANCERA ANNOUNCES INTENTION TO CHANGE COMPANY NAME TO NOVAKAND PHARMA FORMAL DECISION ON NAME CHANGE TO BE MADE ON MAY 26, 2025 Source text: ID:nMFN8LF1r Further company coverage: KANC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing